NICE recommends £3-a-day IBS drug for NHS patients in secondary care

The National Institute for Health and Care Excellence has recommended eluxadoline (Truberzi, Allergan) to be funded on the NHS to treat patients with irritable bowel syndrome and diarrhoea (IBS-D) in secondary care.…